Related references
Note: Only part of the references are listed.Delivery of Exenatide and Insulin Using Mucoadhesive Intestinal Devices
Vivek Gupta et al.
ANNALS OF BIOMEDICAL ENGINEERING (2016)
Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option
Miao Wang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles
Oriane Bouttefeux et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells
Bo Zhang et al.
MICROBIAL CELL FACTORIES (2016)
Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and alpha-glucosidase inhibitory activity
Zhu Zeng et al.
JOURNAL OF FUNCTIONAL FOODS (2016)
Lactic acid bacteria-20 years exploring their potential as live vectors for mucosal vaccination
Agnieszka Wyszynska et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
Pedro Fonte et al.
BIOTECHNOLOGY ADVANCES (2015)
Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
Franklin F. Duan et al.
DIABETES (2015)
Oral films as breakthrough tools for oral delivery of proteins/peptides
Pedro M. Castro et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Incretin-Based Therapies
Joshua J. Neumiller
MEDICAL CLINICS OF NORTH AMERICA (2015)
Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes
Annick V. Hartstra et al.
DIABETES CARE (2015)
Why most oral insulin formulations do not reach clinical trials
Marlene Lopes et al.
THERAPEUTIC DELIVERY (2015)
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
Olivia Cano-Garrido et al.
MICROBIAL CELL FACTORIES (2015)
Probiotic potential and biotherapeutic effects of newly isolated vaginal Lactobacillus acidophilus 36YL strain on cancer cells
Yousef Nami et al.
ANAEROBE (2014)
Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice
Sofie Robert et al.
DIABETES (2014)
Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
Gayatri Sarkar et al.
DIABETES CARE (2014)
Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice
Masaya Miyoshi et al.
EUROPEAN JOURNAL OF NUTRITION (2014)
Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice
Yanjun Ma et al.
PLOS ONE (2014)
Oral Delivery of Glucagon Like Peptide-1 by a Recombinant Lactococcus lactis
Payal Agarwal et al.
PHARMACEUTICAL RESEARCH (2014)
Oral delivery of therapeutic protein/peptide for diabetes - Future perspectives
M. R. Rekha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Functional food ingredients for the management of obesity and associated co-morbidities - A review
Ritesh K. Baboota et al.
JOURNAL OF FUNCTIONAL FOODS (2013)
Nisin-Inducible Secretion of a Biologically Active Single-Chain Insulin Analog by Lactococcus lactis NZ9000
Daphne T. W. Ng et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve
E. V. Khokhlova et al.
ARCHIVES OF MICROBIOLOGY (2010)
Probiotics and the gut microbiota in intestinal health and disease
Melanie G. Gareau et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
E. J. Verspohl
PHARMACOLOGY & THERAPEUTICS (2009)
Protein and Peptide Drug Delivery: Oral Approaches
Jessy Shaji et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Jerry M. Wells et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
P. D. Cani et al.
DIABETOLOGIA (2007)
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
Ina Hubatsch et al.
NATURE PROTOCOLS (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
GLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts
Gang Xu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Delivery of TEM β-lactamase by gene-transformed Lactococcus lactis subsp lactis through cervical cell monolayer
G Kaushal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes
HJ Mest et al.
DIABETOLOGIA (2005)
Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells
Q Wang et al.
DIABETOLOGIA (2004)
Normal flora: living vehicles for non-invasive protein drug delivery
J Shao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line
G Thuret et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and-4
A Thum et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2002)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
Signal peptide and propeptide optimization for heterologous protein secretion in Lactococcus lactis
Y Le Loir et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms
CA Belmokhtar et al.
ONCOGENE (2001)
Secretion of biologically active murine interleukin-10 by Lactococcus lactis
L Schotte et al.
ENZYME AND MICROBIAL TECHNOLOGY (2000)
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas
DA Stoffers et al.
DIABETES (2000)
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion
HE Hohmeier et al.
DIABETES (2000)
Share Paper
